Reimbursement, under conditions, of Wegovy and Mounjaro, since 15 June, resulted in a surge in requests for care by the centres specializing in obesity. The phenomenon reveals the extent of severe obesity in France and the difficulties in following up patients.
Reimbursement, under conditions, of Wegovy and Mounjaro, since 15 June, resulted in a surge in requests for care by the centres specializing in obesity. The phenomenon reveals the extent of severe obesity in France and the difficulties in following up patients.